Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Ceftriaxone Reduced Susceptible Neisseria gonorrhoeae in the Netherlands, 2009 to 2017: From PenA Mosaicism to A501T/V Nonmosaicism.

de Laat MM, Wind CM, Bruisten SM, Dierdorp M, de Vries HJC, Schim van der Loeff MF, van Dam AP.

Sex Transm Dis. 2019 Sep;46(9):594-601. doi: 10.1097/OLQ.0000000000001031.

PMID:
31415041
2.

Molecular diversity of Treponema pallidum subspecies pallidum isolates in Amsterdam, the Netherlands.

Zondag HCA, Cornelissen AR, van Dam AP, Bruisten SM.

Sex Transm Infect. 2019 Aug 5. pii: sextrans-2019-054044. doi: 10.1136/sextrans-2019-054044. [Epub ahead of print]

3.

CEFTRIAXONE REDUCED SUSCEPTIBLE NEISSERIA GONORRHOEAE IN THE NETHERLANDS, 2009-2017: FROM PENA MOSAICISM TO A501T/V NON-MOSAICISM.

de Laat MM, Wind CM, Bruisten SM, Dierdorp M, de Vries HJC, Schim van der Loeff MF, van Dam AP.

Sex Transm Dis. 2019 Jun 14. doi: 10.1097/OLQ.0000000000001031. [Epub ahead of print]

PMID:
31206502
4.

Trends and determinants of antimicrobial susceptibility of Neisseria gonorrhoeae in the Netherlands, 2007 to 2015.

Hofstraat SH, Götz HM, van Dam AP, van der Sande MA, van Benthem BH.

Euro Surveill. 2018 Sep;23(36). doi: 10.2807/1560-7917.ES.2018.23.36.1700565.

5.

[A young man with a scrotal rash; bedbugs or something else?]

van Bergen JEAM, Robberse EJ, van Dam AP.

Ned Tijdschr Geneeskd. 2018 May 16;162. pii: D2766. Dutch.

PMID:
30040323
6.

Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies.

Lääveri T, Vlot JA, van Dam AP, Häkkinen HK, Sonder GJB, Visser LG, Kantele A.

BMC Infect Dis. 2018 Jul 23;18(1):341. doi: 10.1186/s12879-018-3245-z.

7.

Spontaneous Clearance of Pharyngeal Gonococcal Infections: A Retrospective Study in Patients of the Sexually Transmitted Infections Clinic; Amsterdam, the Netherlands; 2012 to 2015.

Hananta IPY, de Vries HJC, van Dam AP, van Rooijen MS, Soebono H, Schim van der Loeff MF.

Sex Transm Dis. 2018 Sep;45(9):594-599. doi: 10.1097/OLQ.0000000000000807.

PMID:
29465642
8.

Molecular epidemiology of Neisseria gonorrhoeae strains circulating in Indonesia using multi-locus variable number tandem repeat analysis (MLVA) and Neisseria gonorrhoeae multi-antigen sequence typing (NG-MAST) techniques.

Hananta IPY, van Dam AP, Schim van der Loeff MF, Dierdorp M, Wind CM, Soebono H, de Vries HJC, Bruisten SM.

BMC Infect Dis. 2018 Jan 5;18(1):7. doi: 10.1186/s12879-017-2940-5.

9.

To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis - Author's reply.

Dessau RB, van Dam AP, Fingerle V, Gray J, Hovius JW, Hunfeld KP, Jaulhac B, Kahl O, Kristoferitsch W, Lindgren PE, Markowicz M, Mavin S, Ornstein K, Rupprecht T, Stanek G, Strle F.

Clin Microbiol Infect. 2018 Feb;24(2):211-212. doi: 10.1016/j.cmi.2017.10.011. Epub 2017 Oct 24. No abstract available.

10.

Monitoring therapy success of urogenital Chlamydia trachomatis infections in women: A prospective observational cohort study.

Versteeg B, Bruisten SM, Heijman T, Vermeulen W, van Rooijen MS, van Dam AP, Schim van der Loeff MF, de Vries HJC, Scholing M.

PLoS One. 2017 Sep 21;12(9):e0185295. doi: 10.1371/journal.pone.0185295. eCollection 2017.

11.

To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis.

Dessau RB, van Dam AP, Fingerle V, Gray J, Hovius JW, Hunfeld KP, Jaulhac B, Kahl O, Kristoferitsch W, Lindgren PE, Markowicz M, Mavin S, Ornstein K, Rupprecht T, Stanek G, Strle F.

Clin Microbiol Infect. 2018 Feb;24(2):118-124. doi: 10.1016/j.cmi.2017.08.025. Epub 2017 Sep 5. Review.

12.

Persistence after treatment of pharyngeal gonococcal infections in patients of the STI clinic, Amsterdam, the Netherlands, 2012-2015: a retrospective cohort study.

Hananta IPY, De Vries HJC, van Dam AP, van Rooijen MS, Soebono H, Schim van der Loeff MF.

Sex Transm Infect. 2017 Nov;93(7):467-471. doi: 10.1136/sextrans-2017-053147. Epub 2017 Aug 19.

13.

Value of light microscopy to diagnose urogenital gonorrhoea: a diagnostic test study in Indonesian clinic-based and outreach sexually transmitted infections services.

Hananta IPY, van Dam AP, Bruisten SM, van der Loeff MFS, Soebono H, Christiaan de Vries HJ.

BMJ Open. 2017 Aug 11;7(8):e016202. doi: 10.1136/bmjopen-2017-016202.

14.

Decreased Azithromycin Susceptibility of Neisseria gonorrhoeae Isolates in Patients Recently Treated with Azithromycin.

Wind CM, de Vries E, Schim van der Loeff MF, van Rooijen MS, van Dam AP, Demczuk WHB, Martin I, de Vries HJC.

Clin Infect Dis. 2017 Jul 1;65(1):37-45. doi: 10.1093/cid/cix249.

PMID:
28510723
15.

A Case-Control Study of Molecular Epidemiology in Relation to Azithromycin Resistance in Neisseria gonorrhoeae Isolates Collected in Amsterdam, the Netherlands, between 2008 and 2015.

Wind CM, Bruisten SM, Schim van der Loeff MF, Dierdorp M, de Vries HJC, van Dam AP.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02374-16. doi: 10.1128/AAC.02374-16. Print 2017 Jun.

16.

Decreased azithromycin susceptibility of Neisseria gonorrhoeae isolates in patients recently treated with azithromycin.

Wind CM, de Vries E, Schim van der Loeff MF, van Rooijen MS, van Dam AP, Demczuk WH, Martin I, de Vries HJ.

Clin Infect Dis. 2017 Mar 24. doi: 10.1093/clinid/cix249. [Epub ahead of print]

PMID:
28369420
17.

Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance, a Novel Antimicrobial Resistance Multilocus Typing Scheme for Tracking Global Dissemination of N. gonorrhoeae Strains.

Demczuk W, Sidhu S, Unemo M, Whiley DM, Allen VG, Dillon JR, Cole M, Seah C, Trembizki E, Trees DL, Kersh EN, Abrams AJ, de Vries HJC, van Dam AP, Medina I, Bharat A, Mulvey MR, Van Domselaar G, Martin I.

J Clin Microbiol. 2017 May;55(5):1454-1468. doi: 10.1128/JCM.00100-17. Epub 2017 Feb 22.

18.

Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.

Wind CM, Schim van der Loeff MF, van Dam AP, de Vries HJ, van der Helm JJ.

Euro Surveill. 2017 Jan 5;22(1). pii: 30431. doi: 10.2807/1560-7917.ES.2017.22.1.30431.

19.

Time to clearance of Chlamydia trachomatis RNA and DNA after treatment in patients coinfected with Neisseria gonorrhoeae - a prospective cohort study.

Wind CM, Schim van der Loeff MF, Unemo M, Schuurman R, van Dam AP, de Vries HJ.

BMC Infect Dis. 2016 Oct 11;16(1):554.

20.

Gonorrhea in Indonesia: High Prevalence of Asymptomatic Urogenital Gonorrhea but No Circulating Extended Spectrum Cephalosporins-Resistant Neisseria gonorrhoeae Strains in Jakarta, Yogyakarta, and Denpasar, Indonesia.

Hananta IP, van Dam AP, Bruisten SM, Schim van der Loeff MF, Soebono H, de Vries HJ.

Sex Transm Dis. 2016 Oct;43(10):608-16. doi: 10.1097/OLQ.0000000000000510.

PMID:
27626188
21.

WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014.

Jacobsson S, Golparian D, Cole M, Spiteri G, Martin I, Bergheim T, Borrego MJ, Crowley B, Crucitti T, Van Dam AP, Hoffmann S, Jeverica S, Kohl P, Mlynarczyk-Bonikowska B, Pakarna G, Stary A, Stefanelli P, Pavlik P, Tzelepi E, Abad R, Harris SR, Unemo M.

J Antimicrob Chemother. 2016 Nov;71(11):3109-3116. Epub 2016 Jul 17.

PMID:
27432597
22.

Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.

Reuland EA, Sonder GJ, Stolte I, Al Naiemi N, Koek A, Linde GB, van de Laar TJ, Vandenbroucke-Grauls CM, van Dam AP.

Clin Microbiol Infect. 2016 Aug;22(8):731.e1-7. doi: 10.1016/j.cmi.2016.05.003. Epub 2016 May 17.

23.

The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis.

Leeflang MM, Ang CW, Berkhout J, Bijlmer HA, Van Bortel W, Brandenburg AH, Van Burgel ND, Van Dam AP, Dessau RB, Fingerle V, Hovius JW, Jaulhac B, Meijer B, Van Pelt W, Schellekens JF, Spijker R, Stelma FF, Stanek G, Verduyn-Lunel F, Zeller H, Sprong H.

BMC Infect Dis. 2016 Mar 25;16:140. doi: 10.1186/s12879-016-1468-4. Review.

24.

Test of Cure for Anogenital Gonorrhoea Using Modern RNA-Based and DNA-Based Nucleic Acid Amplification Tests: A Prospective Cohort Study.

Wind CM, Schim van der Loeff MF, Unemo M, Schuurman R, van Dam AP, de Vries HJC.

Clin Infect Dis. 2016 Jun 1;62(11):1348-1355. doi: 10.1093/cid/ciw141. Epub 2016 Mar 8.

PMID:
26962074
25.

Identification of Neisseria gonorrhoeae by the Bruker Biotyper Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry System Is Improved by a Database Extension.

Schweitzer VA, van Dam AP, Hananta IP, Schuurman R, Kusters JG, Rentenaar RJ.

J Clin Microbiol. 2016 Apr;54(4):1130-2. doi: 10.1128/JCM.00016-16. Epub 2016 Jan 13.

26.

A Dutch nationwide evaluation of serological assays for detection of Borrelia antibodies in clinically well-defined patients.

Ang CW, Brandenburg AH, van Burgel ND, Bijlmer HA, Herremans T, Stelma F, Lunel FV, van Dam AP; Dutch Working Group on Diagnosis of Lyme Borreliosis.

Diagn Microbiol Infect Dis. 2015 Nov;83(3):222-8. doi: 10.1016/j.diagmicrobio.2015.07.007. Epub 2015 Jul 17.

PMID:
26286381
27.

Successful Combination of Nucleic Acid Amplification Test Diagnostics and Targeted Deferred Neisseria gonorrhoeae Culture.

Wind CM, de Vries HJ, Schim van der Loeff MF, Unemo M, van Dam AP.

J Clin Microbiol. 2015 Jun;53(6):1884-90. doi: 10.1128/JCM.00369-15. Epub 2015 Apr 1.

28.

Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilution.

Wind CM, de Vries HJ, van Dam AP.

Int J Antimicrob Agents. 2015 Mar;45(3):305-8. doi: 10.1016/j.ijantimicag.2014.10.020. Epub 2014 Dec 2.

29.

Spontaneous pharyngeal Chlamydia trachomatis RNA clearance. A cross-sectional study followed by a cohort study of untreated STI clinic patients in Amsterdam, The Netherlands.

van Rooijen MS, van der Loeff MF, Morré SA, van Dam AP, Speksnijder AG, de Vries HJ.

Sex Transm Infect. 2015 May;91(3):157-64. doi: 10.1136/sextrans-2014-051633. Epub 2014 Sep 18.

PMID:
25237127
30.

Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report.

van Dam AP, van Ogtrop ML, Golparian D, Mehrtens J, de Vries HJ, Unemo M.

Sex Transm Infect. 2014 Nov;90(7):513-4. doi: 10.1136/sextrans-2014-051552. Epub 2014 Aug 11.

PMID:
25114322
31.

Borrelia burgdorferi sensu lato serology in the Netherlands: guidelines versus daily practice.

Coumou J, Hovius JW, van Dam AP.

Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1803-8. doi: 10.1007/s10096-014-2129-4. Epub 2014 May 17.

PMID:
24838649
32.

Protective effect of hepatitis B virus-active antiretroviral therapy against primary hepatitis B virus infection.

Heuft MM, Houba SM, van den Berk GE, Smissaert van de Haere T, van Dam AP, Dijksman LM, Regez RM, Brinkman K.

AIDS. 2014 Apr 24;28(7):999-1005. doi: 10.1097/QAD.0000000000000180.

PMID:
24685742
33.

Hookworm with hypereosinophilia: atypical presentation of a typical disease.

Verboeket SO, van den Berk GE, Arends JE, van Dam AP, Peringa J, Jansen RR.

J Travel Med. 2013 Jul-Aug;20(4):265-7. doi: 10.1111/jtm.12042. Epub 2013 May 27.

34.

Complement evasion by Borrelia burgdorferi: it takes three to tango.

de Taeye SW, Kreuk L, van Dam AP, Hovius JW, Schuijt TJ.

Trends Parasitol. 2013 Mar;29(3):119-28. doi: 10.1016/j.pt.2012.12.001. Epub 2013 Jan 5. Review.

PMID:
23298533
35.

Risk factors for secondary transmission of Shigella infection within households: implications for current prevention policy.

Boveé L, Whelan J, Sonder GJ, van Dam AP, van den Hoek A.

BMC Infect Dis. 2012 Dec 12;12:347. doi: 10.1186/1471-2334-12-347.

36.

New statistical technique for analyzing MIC-based susceptibility data.

van de Kassteele J, van Santen-Verheuvel MG, Koedijk FD, van Dam AP, van der Sande MA, de Neeling AJ.

Antimicrob Agents Chemother. 2012 Mar;56(3):1557-63. doi: 10.1128/AAC.05777-11. Epub 2012 Jan 9.

37.

Clonally related Neisseria gonorrhoeae isolates with decreased susceptibility to the extended-spectrum cephalosporin cefotaxime in Amsterdam, the Netherlands.

Heymans R, Bruisten SM, Golparian D, Unemo M, de Vries HJ, van Dam AP.

Antimicrob Agents Chemother. 2012 Mar;56(3):1516-22. doi: 10.1128/AAC.05481-11. Epub 2012 Jan 3.

38.

A tick mannose-binding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the lyme disease agent.

Schuijt TJ, Coumou J, Narasimhan S, Dai J, Deponte K, Wouters D, Brouwer M, Oei A, Roelofs JJ, van Dam AP, van der Poll T, Van't Veer C, Hovius JW, Fikrig E.

Cell Host Microbe. 2011 Aug 18;10(2):136-46. doi: 10.1016/j.chom.2011.06.010.

39.

Infectivity of Borrelia burgdorferi sensu lato is unaltered in C3-deficient mice.

van Burgel ND, Balmus NC, Fikrig E, van Dam AP.

Ticks Tick Borne Dis. 2011 Mar;2(1):20-6. doi: 10.1016/j.ttbdis.2010.10.003. Epub 2010 Nov 26.

PMID:
21771533
40.

Problems in comparing test strategies for detection of anti-Borrelia antibodies.

Brandenburg AH, van Dam AP, Schellekens J.

Eur J Clin Microbiol Infect Dis. 2011 Aug;30(8):1033-4; author reply 1035-7. doi: 10.1007/s10096-011-1253-7. Epub 2011 Apr 12. No abstract available.

PMID:
21484251
41.

High sensitivity and specificity of the C6-peptide ELISA on cerebrospinal fluid in Lyme neuroborreliosis patients.

van Burgel ND, Brandenburg A, Gerritsen HJ, Kroes AC, van Dam AP.

Clin Microbiol Infect. 2011 Oct;17(10):1495-500. doi: 10.1111/j.1469-0691.2011.03459.x. Epub 2011 Mar 7.

42.

Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid.

van Burgel ND, Bakels F, Kroes AC, van Dam AP.

J Clin Microbiol. 2011 May;49(5):2027-30. doi: 10.1128/JCM.00084-11. Epub 2011 Mar 2.

43.

Molecular diagnosis of Borrelia bacteria for the diagnosis of Lyme disease.

van Dam AP.

Expert Opin Med Diagn. 2011 Mar;5(2):135-49. doi: 10.1517/17530059.2011.555396. Epub 2011 Feb 8.

PMID:
23480587
44.

Identification and characterization of Ixodes scapularis antigens that elicit tick immunity using yeast surface display.

Schuijt TJ, Narasimhan S, Daffre S, DePonte K, Hovius JW, Van't Veer C, van der Poll T, Bakhtiari K, Meijers JC, Boder ET, van Dam AP, Fikrig E.

PLoS One. 2011 Jan 5;6(1):e15926. doi: 10.1371/journal.pone.0015926.

45.

Severe course of Lyme neuroborreliosis in an HIV-1 positive patient; case report and review of the literature.

van Burgel ND, Oosterloo M, Kroon FP, van Dam AP.

BMC Neurol. 2010 Nov 30;10:117. doi: 10.1186/1471-2377-10-117. Review.

46.

Lyme borreliosis vaccination: the facts, the challenge, the future.

Schuijt TJ, Hovius JW, van der Poll T, van Dam AP, Fikrig E.

Trends Parasitol. 2011 Jan;27(1):40-7. doi: 10.1016/j.pt.2010.06.006. Epub 2010 Jun 30. Review.

PMID:
20594913
47.

Capnocytophaga canimorsus infections in The Netherlands: a nationwide survey.

van Dam AP, Jansz A.

Clin Microbiol Infect. 2011 Feb;17(2):312-5. doi: 10.1111/j.1469-0691.2010.03195.x.

48.

Identification and functional characterisation of Complement Regulator Acquiring Surface Protein-1 of serum resistant Borrelia garinii OspA serotype 4.

van Burgel ND, Kraiczy P, Schuijt TJ, Zipfel PF, van Dam AP.

BMC Microbiol. 2010 Feb 10;10:43. doi: 10.1186/1471-2180-10-43.

49.

Multidrug-resistant Neisseria gonorrhoeae with reduced cefotaxime susceptibility is increasingly common in men who have sex with men, Amsterdam, the Netherlands.

de Vries HJ, van der Helm JJ, Schim van der Loeff MF, van Dam AP.

Euro Surveill. 2009 Sep 17;14(37). pii: 19330.

50.

Molecular characterization of Capnocytophaga canimorsus and other canine Capnocytophaga spp. and assessment by PCR of their frequencies in dogs.

van Dam AP, van Weert A, Harmanus C, Hovius KE, Claas EC, Reubsaet FA.

J Clin Microbiol. 2009 Oct;47(10):3218-25. doi: 10.1128/JCM.01246-09. Epub 2009 Jul 29.

Supplemental Content

Loading ...
Support Center